1st Quarter - Report
CHAMBER HILL STRATEGIES for GLAXOSMITHKLINE, INC.
Client
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Education and importance of various pharmaceutical industry issues, including the Part D prescription drug program within P.L.112-240, the American Taxpayer Relief Act of 2012 and S.Con.Res.8, the Senate Budget Resolution setting forth the Congressional Budget for the U.S. Government for Fiscal Year 2014.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER BELL New | Health Policy Advisor, Sen. Finance Committee |
| MICHAELA SIMS New | Legislative Counsel, Sen. Bob Kerrey |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.